Anxiety
Anxiety is an emotional condition characterized by excessive tension, worry, and an unpleasant state of inner turmoil, often focusing on anticipated future events. Unlike fear, which is a response to a present threat, anxiety is persistent and may include behaviors such as pacing, somatic complaints, and rumination, manifesting in various forms like generalized anxiety, social anxiety, phobias, and panic disorder.
Health Outcomes
- Absence of Adverse Physiological Effects
- Absence of Serious Symptoms such as Septic Shock
- Absence of Severe Adverse Events
- Activation of G-Protein Coupled Receptors
- Activation of Stress Response Pathways
- Altered Brain Activity to Negative Emotional Stimuli
- Altered Catecholamine Level
- Altered Endocannabinoid System Function Due to Specific Strain
- Altered Monoamine Signaling
- Attenuated Stress-Induced Changes in Gut Microbiota
- Changed Heart Rate
- Changes in Health Status from Probiotic Intervention
- Comparable Tolerability
- Elevated Pulse Rate Under Stress
- Elevated Serum Tryptophan Levels
- Enhanced Autonomic Activity Total Power
- Enhanced Autonomic Function
- Enhanced Autonomic Nervous System Activity
- Enhanced BDNF-TrkB Signaling
- Enhanced Brain-Derived Neurotrophic Factor Levels
- Enhanced Host Well-being
- Enhanced Neuropharmacological Function
- Enhanced Parasympathetic Nervous System Activity
- Enhanced Placebo Response
- Enhanced Serotonin Pathway Function
- Enhanced Stress Resistance
- Enhanced Threat Response Appropriateness
- Formation of Biogenic Amines
- Improved Antidepressant Response
- Improved Autonomic Balance
- Improved Behavioral Elements
- Improved Behavioral Health
- Improved Brain-Derived Neurotrophic Factor Level
- Improved Consumer Acceptance
- Improved Coping Strategies
- Improved Depressive Symptoms
- Improved Distress of Life Score
- Improved Emotional Behavior
- Improved Emotional Processing
- Improved Emotional State
- Improved Emotional Well-being
- Improved Enjoyment of Life
- Improved Feeling of Well-being
- Improved General Behavioral Scores
- Improved General Health
- Improved General Well-Being
- Improved Global Assessment
- Improved Glucocorticoid Negative Feedback on the HPA Axis
- Improved Gut-Brain Axis Function
- Improved Gut-Brain Axis Homeostasis
- Improved Gut-Brain Axis Related Neurobehavioral Measures
- Improved Gut-Brain Axis-Related Neuropsychiatric Health
- Improved HPA Axis Response
- Improved Health Perception
- Improved Health Status
- Improved Health Status Score
- Improved Health-related Quality of Life
- Improved Heart Rate Variability
- Improved High-Frequency Power
- Improved Management of Celiac Disease
- Improved Mental Health
- Improved Mental Well-Being
- Improved Mood
- Improved Neuroendocrine Stress Markers
- Improved Neuropsychiatric Outcomes
- Improved Neurotransmitter Profile
- Improved Overall Symptom Relief
- Improved Overall Symptoms
- Improved Parasympathetic Activity
- Improved Parental Mood
- Improved Patient Satisfaction
- Improved Perceived Health
- Improved Perceived Mental Well-being
- Improved Physical and Psychological Performance
- Improved Positive Affect
- Improved Positive Mood Under Stress
- Improved Productive Performance
- Improved Proportion of Healthy Days
- Improved Psychological Status
- Improved Psychological Well-being
- Improved Psychological Wellbeing
- Improved Psychosocial Health-Related Quality of Life
- Improved Quality of Life for IBS-D Patients
- Improved Quality of Life in Individuals with Crohn's Disease
- Improved Regulation of HPA Axis
- Improved Relaxation
- Improved Salivary IgA Levels
- Improved Satisfaction
- Improved Secondary Symptoms
- Improved Serotonin Metabolism
- Improved Sex Life
- Improved Shooting Performance
- Improved Sleep Satisfaction
- Improved Sleep-Related Recovery in Participants with High Chronic Stress
- Improved Social Function
- Improved Social Functioning Quality of Life
- Improved Socialization
- Improved Stress Management
- Improved Stress Response
- Improved Stress Tolerance
- Improved Stress-Related Psychiatric Health
- Improved Sympathetic Tone
- Improved Symptom Score
- Improved Therapeutic Consistency
- Improved Therapy Acceptability
- Improved Total DASS-42 Score
- Improved Total SODA Scores
- Improved Treatment Success
- Improved Vagal Reactivation
- Improved Various Elements
- Improved Waking Quality
- Improved Well-Being
- Improved Work Performance
- Increased 5-Hydroxytryptophan Levels
- Increased Attachment Gain
- Increased BDNF Levels in the Prefrontal Cortex
- Increased Beneficial Gut Bacteria
- Increased Bifidobacteria Levels in Gut Microbiota
- Increased Brain GABA Levels
- Increased Brain-Derived Neurotrophic Factor Levels
- Increased Cortisol Levels
- Increased Distractibility
- Increased Feeding Bouts in the Center of the Open Field
- Increased GABA Production
- Increased GABAergic Signaling
- Increased Heart Rate Response to Stress
- Increased Heart Rate Variability
- Increased Hypocapnic Hyperventilation Area Time
- Increased Insomnia
- Increased Irritability
- Increased Plasma Serotonin Levels
- Increased Production of Beneficial Neurotransmitter GABA
- Increased Proportion of Healthy Days
- Increased Safety
- Increased Salivary Secretory Immunoglobulin A Levels
- Increased Salivary sIgA Levels
- Increased Serotonin Levels
- Increased Serotonin Production
- Increased Serum Serotonin Levels
- Increased Stress Biomarkers
- Increased Systemic GABA Levels
- Increased Treatment Responders
- Increased Treatment Response
- Increased Voluntary Physical Activity
- Increased Voluntary Wheel Running
- Maintained Normal Behavior
- Maintained Positive Mood Under Stress
- Maintained Secretory IgA Levels
- Modulated Endocannabinoid System
- Modulated HPA Axis
- Modulated Microbiota-Gut-Brain Axis
- No Adverse Effects on Food Intake
- No Adverse Health Effects
- No CYP1A2 or CYP3A4 Interaction
- No Change in Appetite Parameters
- No Change in Body Composition
- No Change in Circulating Cytokines
- No Change in Complete Symptom Cessation
- No Change in Cytokines or Chemokines Levels
- No Change in Immune Parameters
- No Change in Immune System Response
- No Change in Interleukin-10 Levels
- No Change in Oxidative Stress Markers
- No Change in Plasma GABA Levels
- No Conclusive Efficacy
- No Effect on Growth Parameters
- No Improvement in IBS Symptoms
- No Negative Impact on Hematological Parameters
- No Reduction in Stress or Anxiety
- No Significant Adverse Events
- No Significant Change in Blood Indices
- No Significant Change in Health Variables
- No Significant Changes in Blood Parameters
- No Significant Changes in Immune Parameters
- No Significant Difference Compared to Placebo
- No Significant Effect on Diarrhea
- No Significant Impact on Immune Response to KLH Immunization
- No Significant Impact on Streptococcal Pharyngitis
- No Significant Increase in Adverse Effects
- No Significant Weight Change
- Normalized Anxiety-Like Behavior in Chronic Colitis
- Normalized Cortisol Levels
- Normalized Neurotransmitter Levels
- Normalized Stress Response
- Reduced Abnormal Brain Plasticity Due to Stress
- Reduced Adherence Attrition
- Reduced Anger
- Reduced Anxiety
- Reduced Anxiety Biomarkers
- Reduced Anxiety Symptoms
- Reduced Anxiety-Related Biomarkers
- Reduced Anxiety-Related Feeding Behavior
- Reduced Anxiety-like Behavior
- Reduced Clinically Relevant Postpartum Anxiety
- Reduced Composite Score
- Reduced Concomitant Medication Usage
- Reduced Corticosterone Levels
- Reduced DASS-21 Score
- Reduced DOPAC Levels in Amygdaloid Cortex
- Reduced Daily Life Disturbance
- Reduced Day School Absenteeism
- Reduced Depression and Anxiety Scores
- Reduced Discontinuation Rates
- Reduced Disturbed Sleep Night
- Reduced Doctor Visits
- Reduced Examination Stress
- Reduced Fecal Cortisol Levels
- Reduced Frequency of Disturbed Sleep
- Reduced Gut Bacteria Associated with Mental Illness
- Reduced HADS Global Score
- Reduced HPA Axis Hyperactivity
- Reduced Health Distress
- Reduced Hyperactivity of the Hypothalamic-Pituitary-Adrenal Axis
- Reduced Incidence of Crying
- Reduced Insomnia
- Reduced Irritability
- Reduced Limbic System Reactivity
- Reduced NREM Sleep Quality
- Reduced Negative Emotional Responses
- Reduced Negative Mood States
- Reduced Non-Pain Symptoms
- Reduced Occurrence of Major Depressive Disorder
- Reduced Overall Symptom Score
- Reduced Overall Symptoms
- Reduced Perceived Stress
- Reduced Performance Choking Under Pressure
- Reduced Physical Symptoms of Stress
- Reduced Post-Exercise Cortisol Response
- Reduced Pre-Examination Physical Symptoms
- Reduced Psychological Distress
- Reduced Psychopathology Symptoms
- Reduced Rearing Behavior
- Reduced Risk of Crying
- Reduced Salivary Cortisol Levels Under Stress
- Reduced Salivary IgA Levels
- Reduced Salivary Serotonin Levels in Response to Stress
- Reduced Serum BDNF Levels
- Reduced Serum Serotonin Levels
- Reduced Severe Feather-Pecking Behavior
- Reduced Sleep Duration
- Reduced Stress Biomarkers
- Reduced Stress Hormone Levels
- Reduced Stress Indicators
- Reduced Stress Levels
- Reduced Stress Markers
- Reduced Stress Response
- Reduced Stress Scores
- Reduced Stress-Induced Hyperpermeability
- Reduced Stress-Induced Reduction in Diurnal Temperature Amplitude
- Reduced Stress-Induced Sleep Disruption
- Reduced Stress-Related Discomfort
- Reduced Subjective Academic Stress
- Reduced Subjective Stress
- Reduced Subjective Stress Levels
- Reduced Subjective Symptoms
- Reduced Symptom Severity
- Reduced Symptom Severity Scale Score
- Reduced Symptoms
- Reduced Total Mood Disturbance
- Reduced Total Side Effects Incidence
- Reduced VIA Positivity
- Regulated Tryptophan Metabolism
- Regulation of Neuroactive Ligand Receptor Interaction Pathway
- Stabilized Physiological Stress Markers
- Symptom Alleviation
- Unchanged Food Intake
- Unchanged Immune Function
- Unchanged Risk of Sepsis
- Unchanged Salivary IgA Levels
- Unchanged Symptom Severity
- Well Tolerated Treatment
- Worsened Depression Score
- Worsened IBS Symptoms